rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
24
|
pubmed:dateCreated |
2011-6-14
|
pubmed:abstractText |
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons that results in progressive muscle weakness and limits survival to 2-5 years after disease onset. Intermediate CAG repeat expansions in ataxin 2 (ATXN2), the causative gene of spinocerebellar ataxia type 2 (SCA2), have been implicated in sporadic ALS. We studied ATXN2 in a large cohort of patients with sporadic and familial ALS.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1526-632X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2066-72
|
pubmed:meshHeading |
pubmed-meshheading:21562247-Adult,
pubmed-meshheading:21562247-Age of Onset,
pubmed-meshheading:21562247-Aged,
pubmed-meshheading:21562247-Aged, 80 and over,
pubmed-meshheading:21562247-Amyotrophic Lateral Sclerosis,
pubmed-meshheading:21562247-Belgium,
pubmed-meshheading:21562247-Female,
pubmed-meshheading:21562247-Humans,
pubmed-meshheading:21562247-Male,
pubmed-meshheading:21562247-Middle Aged,
pubmed-meshheading:21562247-Nerve Tissue Proteins,
pubmed-meshheading:21562247-Netherlands,
pubmed-meshheading:21562247-Pedigree,
pubmed-meshheading:21562247-Spinocerebellar Ataxias,
pubmed-meshheading:21562247-Trinucleotide Repeat Expansion
|
pubmed:year |
2011
|
pubmed:articleTitle |
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
|
pubmed:affiliation |
Department of Neurology, University Hospital Leuven, Leuven, Belgium. wim.robberecht@uzleuven.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|